ACUTE LEUKEMIA
Clinical trials for ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug may boost stem cell transplants for tough leukemia
Disease control Not yet recruitingThis study tests a new approach for adults with relapsed or refractory acute myeloid leukemia (AML) who have active disease. It uses a radioactive drug (131I-apamistamab) combined with low-dose radiation and chemotherapy before a stem cell transplant. The goal is to see if this h…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 07:02 UTC
-
New transplant recipe aims to cut Graft-Versus-Host disease in blood cancer patients
Disease control Not yet recruitingThis early-phase study tests a new combination of chemotherapy drugs (thiotepa, busulfan, fludarabine) with a lower dose of post-transplant cyclophosphamide for stem cell transplants in people with certain blood cancers like leukemia and myelodysplastic syndrome. The goal is to s…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
New hope for young blood cancer patients: QUAIL-100 trial launches
Disease control Not yet recruitingThis early-stage study tests a new drug, QUAIL-100, in 12 children and young adults with high-risk leukemia or myelodysplastic syndrome who have already received a special type of stem cell transplant. The main goal is to check the drug's safety and side effects. Participants wil…
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Laguna Biotherapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New CAR-T therapy made inside the body could cut costs for blood cancer patients
Disease control Not yet recruitingThis early-stage study tests a new type of CAR-T cell therapy that is made inside the body, avoiding the expensive and complex lab process normally needed. It targets two proteins (CD19 and BAFF-R) on cancer cells in people with relapsed or hard-to-treat B-cell acute leukemia or …
Matched conditions: ACUTE LEUKEMIA
Phase: PHASE1 • Sponsor: Qi deng • Aim: Disease control
Last updated May 06, 2026 16:14 UTC